Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 55% ± 22% | |
peripheral blood | 11 studies | 22% ± 7% | |
lung | 9 studies | 36% ± 15% | |
eye | 8 studies | 48% ± 25% | |
heart | 5 studies | 42% ± 14% | |
kidney | 5 studies | 31% ± 13% | |
bone marrow | 4 studies | 26% ± 17% | |
liver | 4 studies | 42% ± 22% | |
adipose | 4 studies | 45% ± 20% | |
intestine | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5552.55 | 1445 / 1445 | 100% | 32.19 | 183 / 183 |
lung | 100% | 5756.08 | 578 / 578 | 99% | 20.20 | 1149 / 1155 |
breast | 100% | 5931.86 | 459 / 459 | 99% | 27.61 | 1112 / 1118 |
intestine | 100% | 6157.68 | 966 / 966 | 99% | 18.72 | 524 / 527 |
ovary | 100% | 6713.41 | 180 / 180 | 99% | 12.51 | 424 / 430 |
stomach | 100% | 5007.19 | 359 / 359 | 99% | 21.84 | 282 / 286 |
brain | 99% | 4076.50 | 2621 / 2642 | 99% | 18.01 | 699 / 705 |
bladder | 100% | 5757.10 | 21 / 21 | 98% | 16.59 | 495 / 504 |
prostate | 100% | 5209.84 | 245 / 245 | 98% | 20.70 | 493 / 502 |
thymus | 100% | 6572.21 | 653 / 653 | 98% | 18.99 | 594 / 605 |
pancreas | 100% | 4416.21 | 328 / 328 | 98% | 17.13 | 174 / 178 |
uterus | 100% | 6564.01 | 170 / 170 | 97% | 15.51 | 445 / 459 |
skin | 100% | 7182.56 | 1809 / 1809 | 96% | 17.32 | 451 / 472 |
kidney | 100% | 4011.89 | 89 / 89 | 94% | 16.28 | 850 / 901 |
adrenal gland | 100% | 6394.81 | 258 / 258 | 90% | 11.45 | 208 / 230 |
liver | 100% | 3229.23 | 226 / 226 | 86% | 8.90 | 351 / 406 |
adipose | 100% | 5740.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6092.99 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.76 | 29 / 29 |
muscle | 100% | 5012.69 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7046.41 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 3322.83 | 835 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 16.79 | 43 / 45 |
peripheral blood | 83% | 4283.20 | 774 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 8.70 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0008283 | Biological process | cell population proliferation |
GO_0051301 | Biological process | cell division |
GO_0060711 | Biological process | labyrinthine layer development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0006915 | Biological process | apoptotic process |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0032465 | Biological process | regulation of cytokinesis |
GO_0030496 | Cellular component | midbody |
GO_0000922 | Cellular component | spindle pole |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0090543 | Cellular component | Flemming body |
GO_0005829 | Cellular component | cytosol |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0005515 | Molecular function | protein binding |
Gene name | BIRC6 |
Protein name | Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Baculoviral IAP repeat containing 6 |
Synonyms | KIAA1289 |
Description | FUNCTION: Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its targets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification. . |
Accessions | A0A3B3IUB9 H7C3P0 A0A8V8TQB4 ENST00000431454.2 ENST00000700518.1 ENST00000421745.7 ENST00000648282.1 ENST00000444173.5 Q9NR09 H7C094 A0A8V8TR92 ENST00000700519.1 |